









Markets
/
Stocks
/
nasdaq-antx
/

AN2 Therapeutics Inc

ANTX

1.050USD

-0.010-0.94%

Close 08/04, 16:00（ET）Quotes delayed by 15 min

31.65MMarket Cap

LossP/E TTM



AN2 Therapeutics Inc

1.050

-0.010-0.94%

Overview Company Financials

Overview

Company

Financials

Statements

Income Statement

Balance Sheet

Cash Flow Statement

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

39.61%-10.62M

69.11%-5.27M

-1.75%-12.01M

-12.16%-14.38M

-51.72%-17.59M

-123.46%-17.07M

-24.38%-11.80M

-33.65%-12.82M

-72.00%-11.60M

---7.64M

---9.49M

---9.60M

---6.74M

Net income from continuing operations

35.92%-10.65M

55.49%-7.52M

23.70%-12.75M

8.66%-14.44M

-8.44%-16.62M

-42.70%-16.90M

-47.34%-16.71M

-56.17%-15.80M

-100.17%-15.32M

---11.84M

---11.34M

---10.12M

---7.66M

Other non-cash items

59.40%-443.00K

56.58%-567.00K

-14.22%-731.00K

-102.27%-890.00K

-162.26%-1.09M

-267.89%-1.31M

-184.44%-640.00K

-730.19%-440.00K

-2289.47%-416.00K

---355.00K

---225.00K

---53.00K

--19.00K

Change in working capital

30.44%-1.58M

194.53%1.04M

-112.76%-431.00K

-190.05%-1.33M

-209.40%-2.27M

-135.50%-1.10M

297.88%3.38M

322.44%1.48M

366.29%2.08M

--3.09M

--849.00K

---664.00K

--445.00K

-Change in prepaid expenses

-41.84%645.00K

231.24%815.00K

-1633.33%-322.00K

31.93%-795.00K

49.46%1.11M

-159.03%-621.00K

-96.69%21.00K

43.82%-1.17M

231.10%742.00K

--1.05M

--634.00K

---2.08M

---566.00K

-Change in other current assets

----

---720.00K

----

-Change in other current liabilities

-21.97%-422.00K

-57.65%-484.00K

-26.31%717.00K

--239.00K

---346.00K

---307.00K

--973.00K

----

Cash from non-recurring investing activities

Cash from operating activities

39.61%-10.62M

69.11%-5.27M

-1.75%-12.01M

-12.16%-14.38M

-51.72%-17.59M

-123.46%-17.07M

-24.38%-11.80M

-33.65%-12.82M

-72.00%-11.60M

---7.64M

---9.49M

---9.60M

---6.74M

Investing cash flow

Net cash flow from investment products

-65.03%9.19M

-1738.10%-6.88M

129.97%18.72M

108.96%16.46M

141.48%26.29M

-93.06%420.00K

-2595.81%-62.46M

119.95%7.88M

-22.11%10.89M

--6.05M

---2.32M

---39.49M

--13.98M

Cash from non-current investing activities

Net cash flow from investing activities

-65.03%9.19M

-1738.10%-6.88M

129.97%18.72M

108.96%16.46M

141.48%26.29M

-93.06%420.00K

-2595.81%-62.46M

119.95%7.88M

-22.11%10.89M

--6.05M

---2.32M

---39.49M

--13.98M

Financing cash flow

Cash flow from continuous financing activities

-81.38%65.00K

100.00%0.00

-99.97%23.00K

-100.00%0.00

75.38%349.00K

---321.00K

660760.00%66.07M

165.39%19.05M

-99.69%199.00K

--0.00

---10.00K

--7.18M

--63.19M

Net cash flow from common stock issuance/repurchase

-69.35%38.00K

--0.00

-99.97%23.00K

-100.00%0.00

-37.69%124.00K

--0.00

659770.00%65.97M

165.39%19.05M

-99.69%199.00K

--0.00

---10.00K

--7.18M

--63.20M

Net cash flow from preferred stock issuance/repurchase

----

--0.00

Proceeds from stock option exercised by employees

-88.00%27.00K

--0.00

-100.00%0.00

--0.00

--225.00K

--0.00

--99.00K

--0.00

100.00%0.00

--0.00

---11.00K

Net cash flow from other financing activities

----

---321.00K

----

Net cash from non-recurrent financing activities

Net cash from financing activities

-81.38%65.00K

100.00%0.00

-99.97%23.00K

-100.00%0.00

75.38%349.00K

---321.00K

660760.00%66.07M

165.39%19.05M

-99.69%199.00K

--0.00

---10.00K

--7.18M

--63.19M

Net cash flow

Beginning cash balance

36.45%21.35M

2.72%33.50M

-34.41%26.77M

-7.55%24.69M

-42.51%15.65M

13.24%32.62M

0.48%40.81M

-67.63%26.71M

125.01%27.22M

--28.80M

--40.62M

--82.52M

--12.10M

Current period cash flow changes

-115.10%-1.37M

28.38%-12.15M

182.17%6.74M

-85.28%2.08M

1873.73%9.05M

-971.95%-16.97M

30.62%-8.20M

133.66%14.10M

-100.72%-510.00K

---1.58M

---11.81M

---41.90M

--70.42M

Ending cash balance

-19.07%19.98M

36.45%21.35M

2.72%33.50M

-34.41%26.77M

-7.55%24.69M

-42.51%15.65M

13.24%32.62M

0.48%40.81M

-67.63%26.71M

--27.22M

--28.80M

--40.62M

--82.52M

Free cash flow

39.61%-10.62M

69.11%-5.27M

-1.75%-12.01M

-12.16%-14.38M

-51.72%-17.59M

-123.46%-17.07M

-24.38%-11.80M

-33.65%-12.82M

-72.00%-11.60M

---7.64M

---9.49M

---9.60M

---6.74M

Currency unit

USD

Audit opinions

KeyAI

